Biofil Chemicals & Pharmaceuticals Limited
BIOFILCHEM · NSE · ₹29 a share (close of 01 Oct 2026)
Available company data, source links and archived checks for Biofil Chemicals & Pharmaceuticals Limited. Read each source and date: a past check is not a fresh review, and some earlier figures have incomplete source details.
Revenue rose 92.0%; Net profit was ₹0.11 crore.
Quarter ended 2026-06-30 · standalone · Company filing
Recorded quarterly figures
| Quarter | Revenue / income | YoY |
Profit | YoY | Net margin | Source |
|---|
| Jun 2026 | Revenue: ₹12 cr | +92.0% | Net profit: ₹0 cr | -95.5% | 0.9% | Company filing source |
| Mar 2026 | Revenue: ₹8 cr | -9.4% | Net profit: ₹0 cr | +6.3% | 2.8% | Company filing source |
| Dec 2025 | Revenue: ₹1 cr | — | Net profit: ₹0 cr | — | 9.2% | Company filing source |
| Sep 2025 | Revenue: ₹14 cr | — | Net profit: ₹0 cr | — | 0.6% | Company filing source |
| Jun 2025 | Revenue: ₹6 cr | -23.8% | Net profit: ₹2 cr | +1324.1% | 37.5% | Company filing source |
| Mar 2025 | Revenue: ₹8 cr | — | Net profit: ₹0 cr | — | 2.4% | Company filing source |
YoY means change from the same quarter a year earlier.
— means no comparable figure is available. Older entries with incomplete source
details have not been revalidated under the current checks.
Who holds it — from the filings
SCOPE FINANCE COMPANY PRIVATE LIMITED 13.9%MID (INDIA) PHARMACEUTICALS PVT LTD 7.2%STARLINE EQUIFIN PRIVATE LIMITED 7.1%CYANO FINANCE AND SALES PVT. LTD. 5.4%MEENA SHAH 4.1%register as filed
2026-06-30
Filing timeline — what the company told the exchange
- Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regu…
24 Sep 2026 · document
- Change in Management. Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about disclosure as required under sub-clause 7 of Para A of Part A o…
24 Sep 2026 · document
- Shareholders meeting. Biofil Chemicals & Pharmaceuticals Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on Septembe…
24 Sep 2026 · document
- Shareholders meeting. Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 23,…
23 Sep 2026 · document
- Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication Pursuant to Regulation 30, 44 and 47 of SEBI (LODR) Reg…
28 Aug 2026 · document
- General Updates. Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about about intimation of e-voting for 41st Annual General Meeting…
26 Aug 2026 · document
- General Updates. Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about draft letter to be dispatched to members whose email addresses not r…
26 Aug 2026 · document
- Shareholders meeting. Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 23…
26 Aug 2026 · document
Follow this company without reading every document yourself.
Keep its available filings, dated fact checks and disclosure alerts together.
Your saved country sets your market and its research schedule.
Start free — first week on us →
India ₹149/month · Rest of world US$4.99/month after the free trial · research, not investment
advice · cancel any time